# Puma Biotechnology (PBYI) — Overview

PBYI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pbyi

## Price

Last close $10.58 on Oct 15, 2026. 52-week range $4.73 – $10.58.

## Company profile

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $231.2M |
| Revenue (quarter) | $56.5M |
| Revenue growth (year over year) | 7.75% |
| Gross profit (trailing twelve months) | $173.0M |
| Gross margin | 74.83% |
| Net income (trailing twelve months) | $26.7M |
| Net income (quarter) | $8.2M |
| Net income growth (year over year) | 39.86% |
| Net margin | 11.55% |
| Return on equity | 21.97% |
| EPS (trailing twelve months) | $0.53 |
| Book value per share | $2.71 |
| P/E (trailing twelve months) | 20.4 |
| Price to book | 3.9 |
| Debt to assets | 28.12% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Puma Biotechnology (PBYI) profitable?

Yes. Puma Biotechnology earned $26.7M in net income over the trailing twelve months, a net margin of 11.55%.

### How much revenue does Puma Biotechnology (PBYI) make?

Puma Biotechnology generated $231.2M in revenue over the trailing twelve months, up 7.75% year over year.

### What is PBYI's P/E ratio?

Puma Biotechnology trades at 20.4 times trailing twelve-month earnings, on an EPS of $0.53.

### How do I buy stock in Puma Biotechnology (PBYI)?

PBYI trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock
- [CTMX](https://www.lighthorse.io/tickers/ctmx) — CytomX Therapeutics, Inc. - Common Stock
- [TRDA](https://www.lighthorse.io/tickers/trda) — Entrada Therapeutics, Inc. - Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).